Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Strides Pharma ×
Actualizaciones regulatorias
18 sept 2026•1 min de lectura
FDA Grants ANDA Approval for Atomoxetine Capsules by Strides Pharma
The FDA approved ANDA 079021 for atomoxetine hydrochloride capsules from Strides Pharma Science, covering strengths from 10 mg to 100 mg.
1
Actualizaciones regulatorias
17 sept 2026•1 min de lectura
FDA Approves Minocycline Hydrochloride Tablets (ANDA 065131)
The FDA approved Strides Pharma's minocycline hydrochloride oral tablets (50 mg, 75 mg, 100 mg) under ANDA 065131, confirming prescription status.
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves Imipramine Hydrochloride (ANDA088292)
FDA grants approval for ANDA088292, an oral imipramine hydrochloride tablet by Strides Pharma Science Limited, with details on dosage, NDC codes, and submission history.